The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI-Reference-Cited by-同舟云学术

The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI

Published:2001-04 Issue:1 Volume:113 Page:126-135
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Soligo Davide,Servida Federica,Delia Domenico,Fontanella Enrico,Lamorte Giuseppe,Caneva Lorenza,Fumiatti Rossella,Lambertenghi Deliliers Giorgio

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.02683.x/fullpdf

Reference35 articles.

1. Proteasome inhibitors: a novel class of potent and effective antitumor agents;Adams;Cancer Research,1999

2. Bcr-abl exerts its effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase 3;Amarantes-Mendes;Blood,1998

3. Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukaemic lymphocytes;Chandra;Blood,1998

4. Mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway;Chang;Cell Growth and Differentiation,1998

5. Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death;Dawson;Journal of Biological Chemistry,1995

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity Threshold in Allogeneic Cells Impacts CTL Response to Nondominant Congenic Antigens;The Journal of Immunology;2023-10-18

2. Protein clearance strategies for disease intervention;Journal of Neural Transmission;2021-10-23

3. Copper(ii)l/d-valine-(1,10-phen) complexes target human telomeric G-quadruplex motifs and promote site-specific DNA cleavage and cellular cytotoxicity;Dalton Transactions;2020

4. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution;Cancer Letters;2019-01

5. Molecular/Targeted Therapy of Cancer;Withrow and MacEwen's Small Animal Clinical Oncology;2019